News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
LifeCycle Pharma Announces First Half 2009 Results, Positive Interim Result for LCP-TacroTM in De Novo Liver Patients and Improves the Full Year Outlook with DKK 100 Million
August 20, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
HØRSHOLM, Denmark--(BUSINESS WIRE)-- Company Announcement no. 15/2009 Interim report for the 6 Months Ended June 30, 2009
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Europe
MORE ON THIS TOPIC
C-suite
Novo drops ‘Nordisk’ moniker, turns bull toward future in corporate rebrand
September 14, 2026
·
3 min read
·
Annalee Armstrong
Manufacturing
Samsung Biologics inks $262M manufacturing deal with European pharma company
September 11, 2026
·
2 min read
·
Nick Paul Taylor
Venture capital
Frazier adds $1.1B+ to small and mid-sized biotech fund
September 11, 2026
·
2 min read
·
Tristan Manalac
Business
Takeda’s long-term R&D head announces exit after major pipeline reorganization
September 10, 2026
·
2 min read
·
Gabrielle Masson
